Mark L. Pacala serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Mark L. Pacala has executed 9 insider transactions totaling $200.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 20, 2025 involved receiving (via award) 46,296 shares valued at $0.
Mark L. Pacala currently holds 221,267 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark L. Pacala has been a net seller of TOI stock. They have purchased $0 and sold $200.0K worth of shares.
Mark L. Pacala's most recent insider trade was on Nov 20, 2025, when they sold 46,296 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 18, 2025 | TOI | $4.8K | Sale | 1,210 | $4.00 | Discretionary |
| Nov 18, 2025 | TOI | $8.6K | Sale | 2,160 | $4.00 | Discretionary |
| Nov 18, 2025 | TOI | $186.5K | Sale | 46,630 | $4.00 | Discretionary |
| Dec 26, 2023 | TOI | $0 | Award | 46,630 | $N/A | Discretionary |
| Mar 17, 2023 | TOI | $0 | Award | 6,562 | $N/A | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 2,160 | $N/A | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 29,057 | $N/A | Discretionary |